Darbitop 40mcg Injection

Price 2450 INR/ Thousand

Get a Price/Quote

MOQ : 5 Vials

Darbitop 40mcg Injection Specification

Pacakaging (Quantity Per Box)
1 prefilled syringe per box

Salt Composition
Darbepoetin alfa 40 mcg

Indication
Treatment of anemia due to chronic renal failure or chemotherapy

Origin of Medicine
Biotechnology/ Recombinant DNA technology

Dosage Form
Injection

Drug Type
Biological; Erythropoiesis-Stimulating Agent

Ingredients
Darbepoetin Alfa

Physical Form
Liquid, Injection

Function
Stimulates erythropoiesis (red blood cell production)

Recommended For
Patients with anemia associated with chronic kidney disease and chemotherapy

Dosage
As prescribed by physician

Dosage Guidelines
Administer via subcutaneous or intravenous injection, as directed by healthcare professional

Suitable For
Adults

Quantity
Single-use prefilled syringe

Storage Instructions
Store at 2°C - 8°C, do not freeze

ATC Code
B03XA02

Brand Name
Darbitop

Strength
40 mcg

Use in Pediatrics
Use only if prescribed and monitored by a specialist

Shelf Life
24 months from manufacturing date

Appearance
Clear, colorless solution

Side Effects
Hypertension, edema, diarrhea, injection site reactions

Caution
For single use only, discard any unused medication after opening

Contraindications
Uncontrolled hypertension, hypersensitivity to Darbepoetin alfa

Administration Route
Subcutaneous or Intravenous

Prescription/Non prescription
Prescription Only

Approval
Approved by DCGI (India) and other regulatory bodies as applicable

About Darbitop 40mcg Injection

Darbitop 40mcg Injection is used in the treatment of anemia that may have occurred due to chronic kidney disease or chemotherapy. It works by stimulating the bone marrow to produce more red blood cells.Darbitop 40mcg Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects. It is important that you seek treatment from a doctor who is experienced in providing this medical therapy. You should follow all the directions of the doctor strictly. It is given under the supervision of a healthcare professional.Common side effects include abdominal pain, high blood pressure, rash, injection site pain, breathlessness, cough, and peripheral edema. Inform your doctor if there are symptoms of very high blood pressure such as severe headache, problems with your eyesight, nausea, vomiting, or fits (seizures).Your doctor may get your blood tests done regularly to monitor the levels of salts (electrolytes such as potassium), hemoglobin, and blood cells in your blood. You should stop taking it and consult with a doctor if you develop shortness of breath or skin rash.Before taking Darbitop 40mcg Injection, tell your doctor if you have heart disease, high blood pressure, or have had a seizure or stroke. If you are pregnant or breastfeeding, or plan to become pregnant or breastfeed, consult your doctor to make sure it is safe for you. ..

Efficient Treatment for Anemia

Darbitop 40mcg Injection is designed to stimulate red blood cell production in patients suffering from anemia due to chronic kidney disease or chemotherapy. With its biotechnology origin, it offers targeted management for a challenging condition, aiming to improve energy and reduce fatigue associated with anemia.

Precise Administration and Safety

The medication is provided in a single-use, prefilled syringe for subcutaneous or intravenous injection, ensuring precision in dosing. Safety protocols dictate discarding any unused product after opening and strict adherence to prescribed dosage, especially in pediatric patients under specialist supervision.

Quality Assured and Regulatory Approved

Darbitop is manufactured following stringent biotechnology standards and carries approval from DCGI and applicable regulatory bodies. Quality assurance extends to its clear, colorless appearance and well-defined storage instructions to maintain efficacy throughout its shelf life of 24 months.

FAQ's of Darbitop 40mcg Injection:

Q: How should Darbitop 40mcg Injection be administered to patients?

A: Darbitop should be administered either subcutaneously or intravenously, strictly as directed by a healthcare professional. The exact route and dosage depend on the individual's condition and physician's guidance.

Q: What are the main benefits of using Darbitop for anemia management?

A: Darbitop effectively stimulates erythropoiesis (red blood cell production), helping alleviate anemia symptoms, such as fatigue and weakness, particularly in patients with chronic renal failure or those undergoing chemotherapy.

Q: When is Darbitop contraindicated for use?

A: Darbitop is contraindicated in individuals with uncontrolled hypertension or known hypersensitivity to Darbepoetin alfa. Always inform your doctor about your medical history before starting this medication.

Q: Where should Darbitop 40mcg Injection be stored to preserve its efficacy?

A: Darbitop must be stored in a refrigerator at temperatures between 2C and 8C. Do not freeze the medication, and keep it out of direct sunlight and reach of children.

Q: What precautions should be followed during the usage of Darbitop?

A: Darbitop is intended for single use only. Any unused solution after opening the syringe should be discarded, and only healthcare professionals should administer the injection to ensure proper technique and dosing.

Q: Can Darbitop 40mcg be used in pediatric patients?

A: Darbitop may be prescribed to pediatric patients only under the guidance and monitoring of a specialist, ensuring the dosage and administration are suitable for the child's specific needs.

Q: What side effects are associated with Darbitop 40mcg Injection?

A: Common side effects include hypertension, edema, diarrhea, and injection site reactions. Inform your healthcare provider immediately if you experience any unusual or severe symptoms while using Darbitop.

Tell us about your requirement